Eisai
Min Cho is an accomplished professional in the field of neuroscience, currently serving as Executive Director of Alzheimer’s Disease Medical Strategy and Integration within Global Medical Affairs at Eisai US since July 2020, after progressing from Senior Director and Director roles. Prior experience includes a position as Publisher and Editor-in-Chief at Wiley for Neuroscience Next and various editorial positions at Springer Nature and Nature Portfolio, focusing on neuroscience publications. Min Cho started a career in research as a Postdoctoral Research Associate at Boston University School of Medicine and as a Staff Research Associate at the University of California, San Francisco. Educational credentials include a Ph.D. in Neuroscience and Molecular Biology from Princeton University and a Bachelor's Degree in Neural Science from New York University.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.